Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A developmental and epileptic encephalopathy characterized by microcephaly, infantile onset of seizures and developmental delay that has material basis in homozygous or compound heterozygous mutation in the PNKP gene on chromosome 19q13.
Features include always present findings: Microcephaly, Seizure, Shrinkage of the cerebellum (cerebellar atrophy), and Global developmental delay and others; and sometimes findings: Hyporeflexia. 15 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 6 | Hyporeflexia, Seizure, Global developmental delay |
PNKP function has not been fully characterized.
Microcephaly, seizures, and developmental delay is caused by mutations in the PNKP gene on chromosome 19.
Genetic testing for PNKP is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for microcephaly, seizures, and developmental delay has been reported in the published literature.
Phenotype severity distribution: 7 always present features.
No clinical trials have been registered for microcephaly, seizures, and developmental delay.
224 publications have been identified in PubMed for microcephaly, seizures, and developmental delay. Kisho has analyzed 139 by research type. Research spans Epidemiology / Natural History (24%), Basic Science / Preclinical (19%), and Case Report / Case Series (17%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 34 | 24% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles
3 |
Skeletal muscle atrophy, Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia) |
Head and neck | 2 | Progressive microcephaly, Microcephaly |
Bones and joints | 1 | Skeletal muscle atrophy |
Age of onset: infancy, adolescence.
Laboratory research |
27 |
19% |
Patient case studies | 24 | 17% |
Research summaries | 23 | 17% |
New treatment approaches | 16 | 12% |
Clinical study results | 8 | 6% |
Testing and diagnosis research | 7 | 5% |
Nou-Fontanet L (2026). [PMID: 41933351](https://pubmed.ncbi.nlm.nih.gov/41933351/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Nieto-Estevez V (2026). [PMID: 41422506](https://pubmed.ncbi.nlm.nih.gov/41422506/). *Cell Rep*. [Basic Science / Preclinical]
Cicala G (2026). [PMID: 41610868](https://pubmed.ncbi.nlm.nih.gov/41610868/). *Neuropediatrics*. [Diagnostic / Biomarker]
Liu M (2026). [PMID: 41982948](https://pubmed.ncbi.nlm.nih.gov/41982948/). *Transl Pediatr*. [Case Report / Case Series]
Wang GH (2026). [PMID: 41983441](https://pubmed.ncbi.nlm.nih.gov/41983441/). *Zool Res*. [Basic Science / Preclinical]
Nishijo T (2026). [PMID: 41742307](https://pubmed.ncbi.nlm.nih.gov/41742307/). *Acta Neuropathol Commun*. [Basic Science / Preclinical]
Morsy H (2026). [PMID: 41570816](https://pubmed.ncbi.nlm.nih.gov/41570816/). *Am J Hum Genet*. [Gene Therapy / Novel Therapeutics]
Torbati PN (2026). [PMID: 41633218](https://pubmed.ncbi.nlm.nih.gov/41633218/). *Pediatric neurology*. [Epidemiology / Natural History]
Zhang G (2026). [PMID: 41133935](https://pubmed.ncbi.nlm.nih.gov/41133935/). *Epilepsia*. [Epidemiology / Natural History]
Datta S (2026). [PMID: 42119404](https://pubmed.ncbi.nlm.nih.gov/42119404/). *Pediatr Neurol*. [Review / Meta-Analysis]